IP Library Granted Patent US 7,875,310
Granted Patent B2
US 7,875,310 · App. 12/382,637 · Granted Jan 25, 2011

Residual solvent extraction method and microparticles produced thereby

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,310
App. No.
12/382,637
Granted
Jan 25, 2011
Kind
B2
Abstract

Methods for preparing microparticles having reduced residual solvent levels. Microparticles are contacted with a non-aqueous washing system to reduce the level of residual solvent in the microparticles. Preferred non-aqueous washing systems include 100% ethanol and a blend of ethanol and heptane. A solvent blend of a hardening solvent and a washing solvent can be used to harden and wash microparticles in a single step, thereby eliminating the need for a post-hardening wash step.

Claims (22)

1. A method for preparing microparticles, comprising:

combining a peptide solution and a polymer solution to form an emulsion, wherein the peptide solution comprises sucrose and exendin or an exendin analog, and the polymer solution comprises a biodegradable, biocompatible polymer dissolved in a halogenated solvent;

combining the emulsion with a coacervating agent that is free from solvents for the polymer to form a combined phase;

extracting the halogenated solvent from the combined phase with an extraction medium of a 9:1 ratio of heptane to ethanol, whereby microparticles precipitate out of the extraction medium; and

rinsing the microparticles with a blend of ethanol and heptane to thereby reduce the level of residual halogenated solvent.

2. The method of claim 1 , wherein the coacervating agent is silicone oil.

3. The method of claim 1 , wherein the coacervating agent is dimethicone.

4. The method of claim 1 , wherein the polymer is selected from the group consisting of poly(glycolic acid), poly(d,l-lactic acid), poly(l-lactic acid), and copolymers of the foregoing.

5. The method of claim 4 , wherein the polymer is poly(d,l-lactic-co-glycolic acid).

6. The method of claim 1 , wherein the rinsing step is carried out until the level of residual halogenated solvent in the microparticles is less than about 0.06% by weight.

7. The method of claim 1 , further comprising after said rinsing step:

final drying of the microparticles.

8. The method of claim 1 , wherein the step of combining the peptide solution and the polymer solution is carried out using a static mixer.

9. A method for preparing microparticles, comprising:

combining a peptide solution and a polymer solution to form an emulsion, wherein the peptide solution comprises sucrose and exendin or an exendin analog, and the polymer solution comprises a 50:50 poly(d,l-lactic-co-glycolic acid) polymer dissolved in methylene chloride;

combining the emulsion with silicone oil to form a combined phase;

extracting the methylene chloride from the combined phase with an extraction medium of a 9:1 ratio of heptane to ethanol, whereby microparticles precipitate out of the extraction medium; and

rinsing the microparticles with a blend of ethanol and heptane to thereby reduce the level of methylene chloride.

10. The method of claim 9 , wherein the rinsing step is carried out until the level of residual methylene chloride in the microparticles is less than about 0.06% by weight.

11. The method of claim 9 , further comprising after said rinsing step:

final drying of the microparticles.

12. The method of claim 9 , wherein the step of combining the peptide solution and the polymer solution is carried out using a static mixer.

Assignments (4)
RELEASE OF PATENT SECURITY AGREEMENT (FIRST LIEN) Recorded Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
RELEASE BY SECURED PARTY (SECOND LIEN) Recorded Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
PATENT SECURITY AGREEMENT (FIRST LIEN) Recorded Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
PATENT SECURITY AGREEMENT (SECOND LIEN) Recorded Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →